Clinical trials
Observational Hyperlipidemias trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
| Completed | 3 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University Third Hospital | 3 |
| AstraZeneca | 1 |
| Capital Medical University | 1 |
| Chinese PLA General Hospital | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Huashan Hospital | 1 |
| Mei Gao | 1 |
| Peking Union Medical College Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 15 |
| Hypertension | 6 |
| Diabetes Mellitus | 3 |
| Renal Insufficiency, Chronic | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Metabolic Syndrome | 2 |
| Obesity | 2 |
| Stroke | 2 |
| Anemia | 1 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.